Diogo T. Mota
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Complement C5 defines two CSU endotypes with distinct autoantibody profiles and omalizumab responses: INCA study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 20, 2026
Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
Journal: The British journal of dermatology
Published: January 11, 2026
Generalized Fixed Drug Eruption Secondary to Etoricoxib.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: September 20, 2024
Flaxseed anaphylaxis: an emerging allergen.
Journal: Porto biomedical journal
Published: June 20, 2024
Asthma and allergy screening in elite soccer athletes: Is it worth it?
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 31, 2024
Fixed drug eruption caused by iodinated contrast media: An unusual hypersensitivity reaction.
Journal: Contact dermatitis
Published: August 10, 2023
Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals.
Journal: Allergy
Published: July 29, 2022
Hypersensitivity to the Moderna COVID-19 Vaccine Caused by Tromethamine: PEG Is Not Always the Culprit Excipient.
Journal: Journal of investigational allergology & clinical immunology
Published: December 20, 2021
AlergiaPT: A Portuguese media campaign to inspire people with allergies to make a positive change in their life.
Journal: Porto biomedical journal
Published: August 25, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026